Healthcare -
Biotechnology - NASDAQ - US
$ 128.0
0.361 %
$ 6.24 B
Market Cap
-21.33
P/E
AXSM - TOTAL LIABILITIES & EQUITY
Total Liabilities & Equity AXSM - Axsome Therapeutics, Inc.
568 M
LAST VALUE
30.96%
2 YEAR CAGR
44.23%
5 YEAR CAGR
70.20%
10 YEAR CAGR